Alto Neuroscience (ANRO) Interest Expenses (2023 - 2026)

Alto Neuroscience (ANRO) reported Interest Expenses of $545000.0 for Q1 2026, down 72.75% on a YoY basis from $2.0 million in Q1 2025, and up 28.24% sequentially from $425000.0 in Q4 2025.

Alto Neuroscience (ANRO) Interest Expenses (2023 - 2026) Analysis & Trends

Alto Neuroscience (ANRO) has 4 years of Interest Expenses data on file, last reported at $545000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Interest Expenses fell 72.75% year-over-year to $545000.0; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (down 17.4% YoY), and the FY2025 full-year result was $52.1 million, up 39.42% from the prior year.
  • Interest Expenses climbed to $545000.0 in Q1 2026, from $425000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.8 billion in Q3 2025 to a low of -$102000.0 in Q4 2023.
  • A 4-year average of $169.8 million and a median of $400000.0 in 2023 frame the typical range for Interest Expenses.
  • Across the five-year window, Interest Expenses jumped 527120.63% in 2025 and plunged 72.75% in 2026, its largest moves.
  • Tracing ANRO's Interest Expenses over 4 years: stood at -$102000.0 in 2023, then surged by 426.47% to $333000.0 in 2024, then climbed by 27.63% to $425000.0 in 2025, then increased by 28.24% to $545000.0 in 2026.
  • Business Quant data shows ANRO's Interest Expenses at $545000.0 in Q1 2026, $425000.0 in Q4 2025, and $1.8 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -42,141.15
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 100,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 32.89 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 420.30 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 28.30 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 1.17 Bn
10 Alto Neuroscience 869.36 Mn 869.36 Mn - 545,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 545,000.00
Mar 31, 2026 545,000.00
Dec 31, 2025 425,000.00
Dec 31, 2025 425,000.00
Sep 30, 2025 1.84 Bn
Sep 30, 2025 1.84 Bn
Jun 30, 2025 362.00 Mn
Jun 30, 2025 362.00 Mn
Mar 31, 2025 2.00 Mn
Mar 31, 2025 2.00 Mn
Dec 31, 2024 333,000.00
Dec 31, 2024 333,000.00
Sep 30, 2024 349,000.00
Sep 30, 2024 349,000.00
Jun 30, 2024 400,000.00
Jun 30, 2024 400,000.00
Mar 31, 2024 346,000.00
Mar 31, 2024 346,000.00
Dec 31, 2023 -102,000.00
Dec 31, 2023 -102,000.00